Loading...
Loading...
CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure. Census population 372,624. Ohio Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Cleveland clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Cleveland storefront.
Build Your Biologic Treatment Center in Cleveland, OH for clinics & physicians. Start or expand your biolo… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure. Census city-proper population is 372,624. If you are adding biologic treatment center, start with that epidemiology and with CGS Administrators (J15) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Build Your Biologic Treatment Center notes (how the product actually works)CDC PLACES (2023, crude) estimates 17.7% of adults in Cleveland have diagnosed diabetes — 5.7 points above the U.S. 12% figure. Adult obesity in Cleveland is 42.2% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 28.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J15 / CGS Administrators, sibling states KY. Ohio Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a Cleveland warehouse or a five-star local review. What you get is biologic treatment center from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J15, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 17.7% of adults — 5.7 points above the U.S. 12% figure. Obesity is 42.2%; arthritis is 28.7%. That is place-level BRFSS modeling, not a clinic census and not a Cleveland trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Regulatory lane, storage, and J15 coding. Amniotic products used as 361 HCT/Ps are not “better gauze.” Match wound stage and coverage article before you convert the cart.
No. They are B2B distribution pages for licensed providers. Patients in Cleveland should speak with their clinician, not use a distributor URL as care instructions.
Ask for the IFU, the lot-traceability packet, and the CGS Administrators article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Cleveland fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Cleveland, OH.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Cleveland is J15 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Cleveland — 5.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Ohio Part B wound biologics follow this contractor (siblings: KY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Cleveland. Useful for joint-program math; still needs a diagnosis and privileging.
No Cleveland storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.